The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Cancer immunotherapy of patients with the biochemical relapse of the prostate cancer using dendritic cell-based vaccine DCVAC/PCa.
Radek Spisek
Employment or Leadership Position - Sotio
Stock Ownership - Sotio
Research Funding - Sotio
Michal Podrazil
No relevant relationships to disclose
Ladislav Jarolim
Research Funding - Sotio
Daniela Rozkova
Employment or Leadership Position - Sotio
Jitka Fucikova
Employment or Leadership Position - Sotio
Anna Fialova
Employment or Leadership Position - Sotio
Jirina Bartunkova
Employment or Leadership Position - Sotio
Stock Ownership - Sotio